MIR6877

Across TCGA pan-cancer cohorts, MIR6877 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR6877’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where MIR6877 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR6877 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

HNSC, COAD, and BRCA are the cancer types where MIR6877 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6877 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	IV	+0.313	.021	5	view →
COAD	All	II,III,IV	+0.323	.019	2	view →
BRCA	Female	All	−0.097	.024	2	view →
LIHC	All	All	+0.071	.022	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

MIR6877–HNSC

Open the HNSC breakdown →